Gsk (GSK) Capital Expenditures (2009 - 2026)
Gsk (GSK) reported Capital Expenditures of -$297.95 million for the quarter ended Mar 31, 2026, compared with -$261.98 million a year earlier.
Powered by 
Analysis
Gsk (GSK) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Gsk's Capital Expenditures came in at $2.75 billion, up 48.2% year-over-year; for the year ended Dec 31, 2025, it came in at $1.78 billion, down 0.6% from the prior year.
- Capital Expenditures has a five-year compound annual growth rate of 7.0% (years ended Dec 2020 to Dec 2025).
- By year, Capital Expenditures came in at $1.79 billion in the year ended Dec 31, 2024 (+9.4%), $1.63 billion in the year ended Dec 31, 2023 (+15.5%), $1.41 billion in the year ended Dec 31, 2022 (+8.2%) and $1.31 billion in the year ended Dec 31, 2021 (+2.9%).
- The figure for the quarter ended Mar 31, 2026 ranks as the lowest quarterly Capital Expenditures since the quarter ended Sep 30, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -297.95 Mn |
| Dec 31, 2025 | 413.68 Mn |
| Mar 31, 2025 | -261.98 Mn |
| Dec 31, 2024 | 2.89 Bn |
| Mar 31, 2024 | -314.59 Mn |
| Dec 31, 2023 | 2.66 Bn |
| Mar 31, 2023 | -283.21 Mn |
| Dec 31, 2022 | 2.17 Bn |
| Mar 31, 2022 | -258.97 Mn |
| Dec 31, 2021 | 2.06 Bn |
| Mar 31, 2021 | -277.16 Mn |
| Dec 31, 2020 | 2.25 Bn |
| Mar 31, 2020 | -252.53 Mn |
| Dec 31, 2019 | 2.64 Bn |
| Sep 30, 2019 | -350.24 Mn |
| Mar 31, 2019 | -289.02 Mn |
| Dec 31, 2018 | 2.81 Bn |
| Mar 31, 2018 | -358.89 Mn |
| Dec 31, 2017 | 3.39 Bn |
| Sep 30, 2017 | -486.78 Mn |
API Access
Gsk Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();